Serum lipid level in Iranian patients with psoriasis
- 12 June 2007
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 21 (6), 802-805
- https://doi.org/10.1111/j.1468-3083.2006.02099.x
Abstract
Psoriasis is a common, chronic, inflammatory and proliferative skin disease associated with abnormal lipid metabolism. Previous studies have demonstrated that patients with psoriasis may have an increased risk of occlusive vascular disease. The aim of this study was to determine lipid profile in Iranian patients with psoriasis. A cross-sectional study was performed in 30 patients with approved psoriasis diagnosis attending the Dermatology Outpatient Department at Sina Hospital, Hamedan, Iran and 30 matched healthy individuals. Fasting blood sugar (FBS), triglyceride, cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) were measured using standard enzymatic method. The psoriasis activity was evaluated by psoriasis area and severity index (PASI Index). FBS levels were higher in patients with psoriasis diagnosis but the differences were not significant (P-value = 0.284). There were no significant differences between serum levels of triglyceride and cholesterol in two groups. There were no differences in lipoproteins (HDL, LDL, VLDL) compared with control subjects. (P-value > 0.05) PASI Index and lipid profile did not have any significant correlation. The correlation between duration of disease and LDL were significant (P-value = 0.033). Lipid profile in Iranian patients with psoriasis did not differ compared with control-matched subjects.Keywords
This publication has 25 references indexed in Scilit:
- Psoriasis is associated with lipid abnormalities at the onset of skin diseaseJournal of the American Academy of Dermatology, 2006
- Smoking and PsoriasisSKINmed: Dermatology for the Clinician, 2005
- Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global AssessmentJournal of the American Academy of Dermatology, 2004
- The variation of serum lipoprotein (a) level with disease activity in psoriasisBritish Journal of Dermatology, 1998
- Disease concomitance in psoriasisJournal of the American Academy of Dermatology, 1995
- Serum lipid and apolipoprotein levels in patients with psoriasisBritish Journal of Dermatology, 1994
- Plasma Lipid Changes in Psoriatic ChildrenDermatology, 1992
- Hypertriglyceridemia in patients with psoriasis treated with cyclosporineJournal of the American Academy of Dermatology, 1991
- Serum Levels of Apolipoproteins AI, All and B in PsoriasisDermatology, 1989
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978